Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million
Company to Accelerate Mass Manufacturing and Commercialization of Proprietary PCR-Free Multi-Omics Technology Following Year of Rapid Growth January 12, 2021 | Source: Cardea Bio Inc. SAN DIEGO–Cardea Bio, Inc., a Tech+Bio […]